Natco Pharma consolidated net profit declines 38.93% in the June 2021 quarter
Sales decline 27.17% to Rs 410.30 crore
Net profit of Natco Pharma declined 38.93% to Rs 75.00 crore in the quarter ended June 2021 as against Rs 122.80 crore during the previous quarter ended June 2020. Sales declined 27.17% to Rs 410.30 crore in the quarter ended June 2021 as against Rs 563.40 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales410.30563.40 -27 OPM %26.7630.37 -PBDT124.80186.10 -33 PBT91.00158.10 -42 NP75.00122.80 -39Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 12 2021 | 3:58 PM IST